• No results found

Median Survival

Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia

Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia

... overall median survival time of endometrial cancer patients was ...the median survival in our study is lower than the medial survival reported in Thailand in 2010 (14) and higher than ...

8

Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study

Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study

... The median survival time was 34 months for patients with well-differentiated neuroendocrine tumors grade G3 and 11 months for poorly differentiated neuroendocrine ...The median survival time ...

9

Treatment of canine and feline hyperadrenocorticism: trilostane and the alternatives

Treatment of canine and feline hyperadrenocorticism: trilostane and the alternatives

... Adrenolytic protocols require giving higher doses of mitotane daily (typically doses of 50 to 100 mg/kg/day given in three or four doses per day) for 25 consecutive days (Rijnberk and Belshaw, 1988; Feldman and Nelson, ...

21

Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer

Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer

... Kaplan-Meier survival curve using IBM SPSS statistic 20 in Figure 2. The median of overall survival was 23 months, while the median survival times are ...

11

Original Article Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma: a single-center experience of 114 cases

Original Article Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma: a single-center experience of 114 cases

... with median survival for patients who do not undergo surgery being 6 months, and the 5-year survival rate for patients following complete resection being only 20%- ...for survival in patients ...

8

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK

... The median survival for MPS I patients (including all phenotypes irrespective of various treatments) was found by Kaplan-Meier analysis to be ...poor survival of patients with the Hurler phenotype ...

7

Photodynamic therapy for cancer of the pancreas

Photodynamic therapy for cancer of the pancreas

... The cancers we treated were not all small, with a maximum diameter at the time of treatment of 2.5–6.0 cm, comparable with the size of those resected in larger surgical series. The three patients in whom no viable tumour ...

10

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences

... overall survival according to different treatment regimens in patients with high grade ...overall survival, followed by patients in group ...(median survival 64.5 months) showed better overall ...

17

Treatment decisions and survival for people with small cell lung cancer

Treatment decisions and survival for people with small cell lung cancer

... found median survival to be longer after completion of six or more cycles of chemotherapy compared with four to five cycles, but cannot conclude that six cycles are preferable to four as we do not have data ...

8

Original Article Mean platelet volume/platelet count ratio is associated with prognosis in patients with pancreatic cancer

Original Article Mean platelet volume/platelet count ratio is associated with prognosis in patients with pancreatic cancer

... Pancreatic cancer is one of the most deadly forms of malignant cancer in the world [1] and has the poorest prognosis among abdominal tumors [2]. Only 20% of pancreatic cancer patients undergo a potentially curable resec- ...

8

Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making

Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making

... into survival functions as presented in Figure 3. Based on the survival functions, the median survival ...expected survival (i.e. mean survival based on the area under the curve ...

12

Multifocal and Multicentric Glioblastoma with Leptomeningeal Gliomatosis: A Case Report and Review of the Literature

Multifocal and Multicentric Glioblastoma with Leptomeningeal Gliomatosis: A Case Report and Review of the Literature

... Glioblastoma (GBM) is the most common intraparenchymal primary brain tumor, representing approximately 30% of all brain tumors and 50% of astrocytomas [1, 2]. GBM is usually located in the deep white matter of the ...

9

Nimotuzumab in Management of Brain Stem Glioma: A Case Report

Nimotuzumab in Management of Brain Stem Glioma: A Case Report

... the survival time when it is used with or without radiotherapy; chemotherapy in high-grade glioma ...in survival rate was (Median survival time ...mean survival time ...

9

Update on HER 2 as a target for cancer therapy: Herceptin in the clinical setting

Update on HER 2 as a target for cancer therapy: Herceptin in the clinical setting

... The median survival in 41 patients who were FISH-positive receiving herceptin as first line monotherapy was 23 months, compared with a median survival of ...

5

Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011.

Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011.

... the survival of live births with trisomy 18 and trisomy 13 and their ...about survival. Survival was known for 326 (88%) of live births with trisomy 18 and 142 (82%) of live births with trisomy 13 ...

22

Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer

Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer

... overall survival rate was 47.5%, and the survival time was 8–70 ...patient survival time, the median survival time of dif- ferent patients, and the differences in intensity of Fascin-1 ...

6

Survival Outcomes of Metastatic Colorectal Cancer Patients in Brunei Darussalam and the Impact of KRAS Mutations

Survival Outcomes of Metastatic Colorectal Cancer Patients in Brunei Darussalam and the Impact of KRAS Mutations

... the survival outcome of metastatic Colorectal cancer mCRC) patients in Brunei Darussalam ...the survival outcomes of mCRC patients, and Mann-Whitney U test was used to compare the median ages of both ...

19

Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma

Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma

... reported median survival times of about 14-20 months in the most studies and the median survival of ...estimated survival of ...

5

Prognostic Factors in Elderly Patients with High-grade Gliomas: A Retrospective Analysis of 24 Cases.

Prognostic Factors in Elderly Patients with High-grade Gliomas: A Retrospective Analysis of 24 Cases.

... with median survival 12 months for patients who underwent complete resection versus 5 months for patients with subtotal resection/ ...with median survival of 12–24 and 6–9 months, ...

5

Outcome of recurrent and metastatic small cell carcinoma of the bladder

Outcome of recurrent and metastatic small cell carcinoma of the bladder

... considered. Survival was analyzed statistically in all patients. Overall survival was calculated from the date of diagnosis of recurrent or metastatic disease to the date of death or to the date of last ...

8

Show all 10000 documents...

Related subjects